NDATOPICALCREAM
Approved
May 2022
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
4
Mechanism of Action
Aryl Hydrocarbon Receptor Agonists
Pharmacologic Class:
Aryl Hydrocarbon Receptor Agonist
Clinical Trials (4)
Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis
Started Dec 2024
560 enrolled
Plaque Type Psorisis
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
Started Aug 2019
763 enrolled
Plaque Psoriasis
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
Started Jun 2019
515 enrolled
Plaque Psoriasis
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
Started May 2019
510 enrolled
Plaque Psoriasis
Loss of Exclusivity
LOE Date
Nov 13, 2039
166 months away
Patent Expiry
Nov 13, 2039
Exclusivity Expiry
Dec 12, 2027